<Document>
	<CASIS.DOCNO>
		<orgianl>DGL1510302</orgianl>
	</CASIS.DOCNO>
	
	
	<CASIS.UPD>
		<PublicationDate CCYYMMDD="20141028">28 Oct 2014
		</PublicationDate>
	</CASIS.UPD>
	<LaunchDetails>
		<LaunchDateComment />
		<NewChemicalEntity />
		<Ingredients>
			<Ingredient>ribavirin</Ingredient>
		</Ingredients>
		<CASIS.USE>
			<CASIS.ACT>
				<Class>
					<ClassCode>J5B</ClassCode>
					<ClassDescription>Antivirals</ClassDescription>
				</Class>
			</CASIS.ACT>
			<CASIS.IND>
				<Indication>Chronic hepatitis C infection.</Indication>
			</CASIS.IND>
		</CASIS.USE>
		<CASIS.CN>
			<BrandName>MODERIBA</BrandName>
		</CASIS.CN>
		<CASIS.CO>
			<CASIS.NORMALIZED.CO>Manufacturer: Abbvie</CASIS.NORMALIZED.CO>
			<CASIS.NORMALIZED.CO>ABBVIE</CASIS.NORMALIZED.CO>
			<Manufacturer>Abbvie</Manufacturer>
			<Corporation>ABBVIE</Corporation>
		</CASIS.CO>
		<CASIS.DSTA>
			<CASIS.NORMALIZED.DSTA>SF: Launched 20140801</CASIS.NORMALIZED.DSTA>
			<Country>Finland</Country>
			<LaunchDate CCYYMM="20140801">01 Aug 2014</LaunchDate>
		</CASIS.DSTA>
		<CASIS.TX>
			<Biotech>No</Biotech>
			<Unbranded>No</Unbranded>
		</CASIS.TX>
		<CASIS.RN>
			<CASInfo>
				<CASItem />
			</CASInfo>
		</CASIS.RN>
	</LaunchDetails>
	<PackInfo>
		<ExcipientInfo>
			<Excipient />
		</ExcipientInfo>
		<PriceInfo>
			<Price>tabs film-coated a 168: EUR 818.540 (RPP)</Price>
			<Price>tabs film-coated b 56: EUR 545.690 (RPP)</Price>
		</PriceInfo>
		<DoseFormInfo>
			<DoseForm>tabs film-coated</DoseForm>
		</DoseFormInfo>
		<NumberOfIngredients>1</NumberOfIngredients>
		<CASIS.TX>
			<CompositionInfo>
				<Composition>tabs film-coated a: ribavirin base, 200 mg
				</Composition>
				<Composition>tabs film-coated b: ribavirin base, 400 mg
				</Composition>
			</CompositionInfo>
		</CASIS.TX>
	</PackInfo>
	<LaunchStatus>
		<RecordStatus />
	</LaunchStatus>
	<CASIS.MDNUMBER>MD000001</CASIS.MDNUMBER>
</Document>